BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7157722)

  • 1. [Role of glycogenolysis inhibition in the etiology of arrhythmias in coronary disease].
    Sysoliatina NA; Sapozhkov AV
    Vopr Med Khim; 1982; 28(6):56-9. PubMed ID: 7157722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endo- and epicardial glycogenolysis by propranolol in ischemic hearts.
    Ichihara K; Abiko Y
    Am J Physiol; 1977 Apr; 232(4):H349-53. PubMed ID: 851197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Energy formation processes in the myocardium during measured limitation of coronary blood flow].
    Frol'kis RA; Tsiomik VA; Likhtenshteĭn IE; Evstratova IN
    Vopr Med Khim; 1981; 27(1):47-51. PubMed ID: 6258321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nitroglycerin, dipyridamole, and propranolol on glycogen metabolism during coronary artery ligation in dogs.
    Ichihara K; Abiko Y
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():531-5. PubMed ID: 829648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmural gradients in the ischemic dog left ventricle: metabolism of endogenous triglycerides and glycogen.
    Crass MF; Holsinger JW; Shipp JC; Eliot RS; Pieper GM
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():225-30. PubMed ID: 1226437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of prolonged beta-adrenergic blockade on myocardial energy metabolism in coronary occlusion].
    Sysoliatina NA
    Farmakol Toksikol; 1982; 45(4):41-6. PubMed ID: 7128783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of catecholamine in activating glycogenolysis in experimental myocardial infarct complicated by ventricular fibrillation].
    Dolgova NP
    Kardiologiia; 1982; 22(7):101-5. PubMed ID: 6287086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of isoprenaline, propranolol and alprenolol on the glycogen phosphorylase activity and glycogen level of the heart of neonate and adult rats.
    Brus R
    Pol J Pharmacol Pharm; 1973; 25(5):423-8. PubMed ID: 4777345
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of dopamine on glucose level and glycogen phosphorylase activity of blood plasma in experimental coronary occlusion].
    Sysoliatina NA
    Biull Eksp Biol Med; 1993 Mar; 115(3):271-2. PubMed ID: 8054619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The time course of myocardial glycogenolysis stimulated by glucagon.
    Laughlin MR; Petit WA; Barrett EJ
    J Mol Cell Cardiol; 1993 Feb; 25(2):175-83. PubMed ID: 8474125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemia-induced changes in the phosphorylase activity in different parts of the cardiac conduction system.
    Petkova I; Zhelcheski B
    Cor Vasa; 1988; 30(2):153-9. PubMed ID: 3391039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of trimetazidine on utilization of myocardial glycogen during coronary ligation in dogs.
    Sakai K; Fukushi Y; Abiko Y
    Pharmacology; 1986; 32(2):72-9. PubMed ID: 3952133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the release of glycogen phosphorylase from heart muscle: effect of substrate depletion, ischemia and of imipramine.
    Krause EG; Härtwig A; Rabitzsch G
    Biomed Biochim Acta; 1989; 48(2-3):S77-82. PubMed ID: 2658984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclic AMP levels in the plasma and ischemic myocardium and free fatty-acid levels in the serum following coronary artery ligation in dogs: relation to ventricular fibrillation].
    Huang DX; Dong J
    Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):457-9, 507-8. PubMed ID: 2557190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial carbohydrate metabolism in limited coronary blood flow].
    Likhtenshteĭn IE
    Kardiologiia; 1981 Jun; 21(6):97-100. PubMed ID: 6267347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference between endocardial and epicardial utilization of glycogen in the ischemic heart.
    Ichihara K; Abiko Y
    Am J Physiol; 1975 Dec; 229(6):1585-9. PubMed ID: 1082247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in myocardial norepinephrine and glycogen phosphorylase in ischemic and non-ischemic areas].
    Sakai K; Abiko Y
    Kokyu To Junkan; 1983 Jan; 31(1):15-8. PubMed ID: 6857010
    [No Abstract]   [Full Text] [Related]  

  • 18. [Course of acute myocardial ischemia in dogs depending on the pharmacological background].
    Koriukin VM; Prianishnikov VA
    Biull Eksp Biol Med; 1979 May; 87(5):429-32. PubMed ID: 454821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of niludipine on ischemic myocardial metabolism in the dog.
    Ichihara K; Ichihara M; Abiko Y
    Arzneimittelforschung; 1980; 30(5):785-91. PubMed ID: 7190421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phosphorylase activity and glycogen content in cerebral and myocardium tissues in rats of different age].
    Bogatskaia LN; Potapenko RI
    Ukr Biokhim Zh (1978); 1980; 52(4):457-61. PubMed ID: 6782725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.